Quarterly report pursuant to Section 13 or 15(d)

Investment (Details)

v3.22.0.1
Investment (Details) - USD ($)
12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2021
Schedule of Equity Method Investments [Line Items]      
Fair value of DepYmed preferred shares assumed in connection with acquisition of Ohr $ 99,020    
DepYmed preferred shares received in sale of intellectual property 316,724    
Total Investment 415,744    
DepYmed      
Schedule of Equity Method Investments [Line Items]      
Percentage of ownership held     15.00%
Equity in losses on equity method investment $ 400,000 $ 30,000.00